The lung cancer-associated blood biomarker hPG80 exhibits a reversible increase in response to smoking in asymptomatic individuals

dc.contributor.authorBérengère Vire
dc.contributor.authorLéa Payen
dc.contributor.authorClaire Vignault
dc.contributor.authorVéronique Hofman
dc.contributor.authorCharles‐Hugo Marquette
dc.contributor.authorJean‐Philippe Berthet
dc.contributor.authorJacques Boutros
dc.contributor.authorMarius Ilié
dc.contributor.authorGuillaume Pénaranda
dc.contributor.authorPhilippe Pourquier
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T19:49:38Z
dc.date.available2026-03-22T19:49:38Z
dc.date.issued2025
dc.identifier.doi10.1186/s40364-025-00861-4
dc.identifier.urihttps://doi.org/10.1186/s40364-025-00861-4
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/78354
dc.language.isoen
dc.publisherBioMed Central
dc.relation.ispartofBiomarker Research
dc.sourceFundación PROINPA
dc.subjectAsymptomatic
dc.subjectMedicine
dc.subjectBiomarker
dc.subjectCOPD
dc.subjectInternal medicine
dc.subjectLung cancer
dc.subjectGastroenterology
dc.subjectLung
dc.subjectOncology
dc.subjectDiagnostic biomarker
dc.titleThe lung cancer-associated blood biomarker hPG80 exhibits a reversible increase in response to smoking in asymptomatic individuals
dc.typearticle

Files